Formulation Scientist II

Formulation Scientist II

Quotient Sciences

Reading, United Kingdom

The Role

  • To lead pre-clinical or stand-alone formulation programmes requiring specialist formulation knowledge;
  • To design and conduct formulation development work including pre-formulation and formulation characterisation;
  • To support the transfer of formulation development programs into GMP clinical manufacturing with input on manufacturing protocols, validation criteria and other key parameters;
  • To write experimental protocols and reports.

Main Tasks And Responsibilities

  • Lead pre-clinical formulation development programmes;
  • To plan experiments and write protocols and reports, according to an agreed work schedule;
  • Provide support on cross-site projects/technology transfer as required;
  • Accurate analysis and calculation of results, in line with written Protocol and /or SOPs of the company;
  • To prepare and characterise formulations;
  • Train new/existing staff as required;
  • Keeping detailed and accurate records of all work undertaken;
  • To communicate progress of in vitro and in vivo projects effectively to senior managers or Quotient staff as required;
  • To be aware of the need for confidentiality outside the company;
  • To perform other duties as reasonably required;
  • Work in a safe responsible manner at all times to GMP.

Additional Tasks/responsibilities

  • Provide formulation expertise to support other formulation scientists within the group;
  • To source and control formulation excipients.

Qualifications And Experience Required For Competent Performance

  • Minimum degree level qualification in pharmacy or chemistry related discipline;
  • >5 years’ experience in formulation development;
  • cGMP experience will be at advantage.

Apply Now

Don't forget to mention EuroPharmaJobs when applying.

Share this Job

More Job Searches

United Kingdom      On-site      Pre-clinical Research and Development      Quotient Sciences     

EuroPharmaJobs Logo

© EuroJobsites 2025